Sudarshan Chemical Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.45×0.32×0.62×0.76×0.75×
0.62×0.52×0.45×2.68×0.62×
3.2%2.5%6.4%6.9%4.2%
1.01×1.01×0.55×1.07×0.96×
2.52×2.52×2.41×2.05×2.89×
2.3%1.1%2.4%30.9%5.4%
0.7%0.7%2.4%36.2%5.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUDARSCHEM₹1,014.00

Sudarshan Chemical Industries Ltd.

· Chemicals
₹ CrorePeersSUDEEPPHRMSTYRENIXSHARDACROPREFEXRCFRALLISRAINPRIVISCLMcap ₹7,960 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.760.620.320.45
Interest Burden (Pretax/EBIT) ×0.622.680.450.520.62
EBIT Margin %4.196.906.422.483.17
Asset Turnover ×0.961.070.551.011.01
Financial Leverage (Assets/Equity) ×2.892.052.412.522.52
ROE (5-step product, year-end total equity) %5.3930.882.381.062.29
ROE (owners' profit / average owners' equity) %5.4136.162.430.650.65
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.